Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,527,620 papers from all fields of science
Search
Sign In
Create Free Account
Triptans
Derivatives of TRYPTAMINES that are SEROTONIN RECEPTOR AGONISTS acting at 5-HT1 RECEPTORS. Some are used to treat MIGRAINE DISORDERS.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Serotonin 5-HT1 Receptor Agonists
Tryptamines
Narrower (1)
Sumatriptan
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
The role of triptans in the management of migraine
Universa Medicina
2009
Corpus ID: 55286148
Migraine is one of the most prevalent disorders seen in clinical practice today and also a major cause of disability in the…
Expand
2008
2008
Triptans and Serotonin Syndrome
R. Evans
Cephalalgia
2008
Corpus ID: 29993955
Dear Sir I read the article, ‘Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and…
Expand
Review
2006
Review
2006
Topiramate Prophylaxis and Response to Triptan Treatment for Acute Migraine
W. Becker
,
S. Christie
,
S. Ledoux
,
C. Binder
Headache
2006
Corpus ID: 46380444
Objective.—To evaluate the effect of topiramate migraine prophylaxis on subject responsiveness to triptans used for acute…
Expand
Review
2006
Review
2006
Utilisation clinique des triptans dans la prise en charge de la migraine
M. Lanteri-minet
2006
Corpus ID: 73004320
The discovery of the triptans (selective serotonin agonists 5HT1B/1D), with 7 compounds (almotriptan, eletriptan, frovatriptan…
Expand
2006
2006
Making gains in pain
Leland J. Gershell
,
J. Goater
Nature reviews. Drug discovery
2006
Corpus ID: 30212815
Taking the edge off migraine It is estimated that around 11% of the adult population in the Western world suffers from migraine…
Expand
Review
2006
Review
2006
Oral Triptans vs. Other Classes of Acute Migraine Medication
P. Tfelt‐Hansen
Cephalalgia
2006
Corpus ID: 46109825
Dear Sir In their recent review of oral triptans vs. other classes of acute migraine medication, Lipton et al. (1) speculate on…
Expand
2005
2005
Naratriptan in the Preventive Treatment of Refractory Transformed Migraine: A Prospective Pilot Study
F. Sheftell
,
A. Rapoport
,
S. Tepper
,
M. Bigal
Headache
2005
Corpus ID: 6341621
Objective.—To assess the efficacy, safety, and tolerability of daily naratriptan in the preventive treatment of transformed…
Expand
Review
2004
Review
2004
Views and Perspectives Consensus Statement: Cardiovascular Safety Profile of Triptans (5-HT 1B/1D Agonists) in the Acute Treatment of Migraine
D. Dodick
,
R. Lipton
,
+10 authors
R. Purdy
2004
Corpus ID: 78429555
Background.—Health care providers frequently cite concerns about cardiovascular safety of the triptans as a barrier to their use…
Expand
2004
2004
When to Stress Over Triptans: A Markov Analysis of Cardiovascular Risk in Migraine Treatment
L. Orlando
,
D. Matchar
Headache
2004
Corpus ID: 28241022
Background.—Migraines affect 10% of the U.S. population and the episodes are frequently associated with significant disability…
Expand
Review
2001
Review
2001
Acute treatment of migraine and the role of triptans
F. Freitag
Current Neurology and Neuroscience Reports
2001
Corpus ID: 24581378
The use of triptans has improved the ability to treat migraine successfully compared with older treatments. Speed of relief…
Expand